Cernuumolide J
Cernuumolide J (TMJ-105) is an JAK2/STAT3 inhibitor. Cernuumolide J induces G2/M phase arrest and apoptosis in HEL leukemia cells by downregulating the phosphorylation of JAK2, STAT3, and Erk, and activating the phosphorylation of JNK and p38 MAPK. Cernuumolide J inhibits HEL leukemia cell growth in a time- and concentration-dependent manner, with an IC50 value of 1.79 μM. Cernuumolide J can be used for research in the field of anti-cancer therapy[1].
Product Specifications
CAS Number
2019163-02-9
Product Name Alternative
TMJ-105
UNSPSC
12352005
Target
Apoptosis; ERK; JAK; JNK; p38 MAPK; STAT
Type
Natural Products
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; MAPK/ERK Pathway; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cernuumolide-j.html
Smiles
CC(C)C(O[C@@H]1[C@]2([H])[C@@](C(C(O2)=O)=C)([H])[C@@H](C([C@@H](CCC[C@@]1(O)C)C)=O)OC(/C(C)=C\C)=O)=O
Molecular Formula
C24H34O8
Molecular Weight
450.52
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
JNK3; STAT3
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
